-       Report 
- January 2025
-  153 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- October 2025
-  291 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- January 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Clinical Trials 
- April 2025
-  80 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
          -       Drug Pipelines 
- June 2025
-  200 Pages 
- Global 
   From       €2495EUR$2,789USD£2,194GBP 
             -       Report 
- May 2025
-  131 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
            -       Report 
- August 2025
-  182 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- May 2024
-  133 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- January 2022
-  60 Pages 
- Global 
   From       €2826EUR$3,160USD£2,486GBP 
      €3533EUR$3,950USD£3,108GBP 
          -       Report 
- January 2022
-  110 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
            -       Report 
- May 2024
-  131 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
          -       Report 
- November 2023
-  157 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- October 2024
-  58 Pages 
- Global 
   From       €3573EUR$3,995USD£3,143GBP 
          -       Report 
- November 2021
-  177 Pages 
- Global 
   From       €13412EUR$14,995USD£11,798GBP 
       
      The Sepsis Drug market is a subset of the larger Infectious Diseases Drugs market. Sepsis is a life-threatening condition caused by the body's response to an infection. It is a major cause of death worldwide, and the drugs used to treat it are an important part of the Infectious Diseases Drugs market. Sepsis drugs are typically antibiotics, antifungals, antivirals, and other immunomodulators. These drugs are used to reduce the severity of the infection and to prevent further complications.
The    Sepsis Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Johnson & Johnson. Other companies such as Novartis, Bristol-Myers Squibb, and Eli Lilly also have a presence in the market. Show Less   Read more